@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ns1: <http://purl.org/spar/datacite/> .
@prefix ns2: <http://purl.org/spar/pro/> .
@prefix ns3: <http://prismstandard.org/namespaces/basic/2.0/> .
@prefix ns4: <http://purl.org/vocab/frbr/core#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<> dcterms:license <https://creativecommons.org/publicdomain/zero/1.0/legalcode> .

<https://w3id.org/oc/meta/br/061603860708> a <http://purl.org/spar/fabio/Expression>,
        <http://purl.org/spar/fabio/JournalArticle> ;
    rdfs:label "br 061603860708" ;
    ns3:publicationDate "2023-05-31"^^xsd:date ;
    dcterms:title "Efficacy And Safety Of Two-Drug Regimens That Are Approved From 2018 To 2022 For The Treatment Of Human Immunodeficiency Virus (HIV) Disease And Its Opportunistic Infections" ;
    ns1:hasIdentifier <https://w3id.org/oc/meta/id/061604352011>,
        <https://w3id.org/oc/meta/id/0697091032> ;
    ns2:isDocumentContextFor <https://w3id.org/oc/meta/ar/0616015410211>,
        <https://w3id.org/oc/meta/ar/0616015410212>,
        <https://w3id.org/oc/meta/ar/0616015410213>,
        <https://w3id.org/oc/meta/ar/0616015410214>,
        <https://w3id.org/oc/meta/ar/0616015410215>,
        <https://w3id.org/oc/meta/ar/0616015410216> ;
    ns4:embodiment <https://w3id.org/oc/meta/re/061602585490> ;
    ns4:partOf <https://w3id.org/oc/meta/br/061703867884> .

